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Summary Mycobacterium species adhere to the respiratory mucosa via mucus and
fibronectin of extracellular matrix exposed by damaged epithelium. We have
investigated whether inhibiting adherence to fibronectin influences subsequent
infection of human respiratory tissue by Mycobacterium avium complex and
Mycobacterium tuberculosis. Human respiratory tissue was pretreated with
mycobacterial fibronectin attachment proteins prior to infection with M. avium
complex and M. tuberculosis and the number of recoverable bacteria over time
was compared to untreated controls. Inhibition significantly reduced recovery of
M. avium complex at 15min (P ¼ 0:02), 7 days (P ¼ 0:04), and 14 days (P ¼ 0:03);
whereas recovery of M. tuberculosis was only reduced at 15min (P ¼ 0:01) and not at
later timepoints. We conclude that M. avium complex and M. tuberculosis infection
of the mucosa proceeds by different mechanisms, since M. tuberculosis infection is
independent of fibronectin adherence.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Mycobacterium avium complex (MAC) and Mycobac-
terium tuberculosis (MTB) both cause pulmonary
disease in humans. MAC is less virulent than MTB,
and is generally referred to as an opportunistic or
facultative pathogen. Although MAC infections do
occur in patients without any respiratory history,
most patients have prior lung damage. In these
cases, the primary site of infection may be the
airway mucosa. In contrast, MTB is an obligate
human pathogen transmitted from patient-to-pa-
tient in aerosols of respiratory secretions and the
primary route of infection of MTB is regarded as via
interaction with the alveolar macrophages. Little is
known about the virulence factors of MAC and MTB
and whether they possess any that are specifically
relevant to mucosal infections. We have previously
investigated the role of adherence to fibronectin in
the interaction of mycobacteria with the respiratory
mucosa.1 In these studies, mycobacteria adhered to
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mucus with a fibrous appearance. They also adhered
rarely to healthy unciliated epithelium, degener-
ated extruded epithelial cells and open tight
junctions between epithelial cells.2,3
There have been a number of reported mechan-
isms of mycobacterial attachment to host cells,
including heparin-binding haemagglutinin interac-
tion with epithelial cells and at least five myco-
bacterial components that bind with HEp-2 cell
extracts.4,5 Two distinct mycobacterial proteins or
protein complexes, fibronectin attachment protein
(FAP) and proteins of the antigen 85 complex, are
involved in mycobacterial attachment to fibronec-
tin.3,6 The ability to bind fibronectin is highly
conserved in mycobacteria.3,7 We have previously
shown that pre-incubation of MAC and MTB with
soluble fibronectin and pre-incubation of tissue
with FAP and/or antigen 85B protein (a85B)
resulted in significant inhibition of the bacterial
adherence to fibronectin exposed in areas of
damage on the mucosal surface of organ cultures
of human respiratory tissue.1,2 Antigen 85B protein,
was selected for these experiments as it has been
shown to be simultaneously associated with the
bacterial cell wall as well as being secreted.8
We have also previously studied the interaction
of MAC and MTB with the respiratory mucosa over
14 days where we showed that MAC increased in
numbers extracellularly on the mucosal surface
whereas MTB was lost from the surface, but
invaded the organ culture and multiplied within
the tissue.9 We have now investigated the effect of
inhibiting adherence to fibronectin with FAP and
a85B combined on MAC and MTB infection of human
respiratory mucosa in an organ culture model with
an air interface incubated over 14 days. We
hypothesized that the interaction of MAC with
fibronectin may be a more important pathogenic
mechanism for MAC than MTB, and that by
inhibiting adherence we may be able to reduce or
prevent infection of the organ culture.
Materials and methods
The organ culture using human nasal turbinate and
bronchial tissue has been described pre-
viously.1,10,11 Each experiment required 12 pieces
of dissected tissue from the same donor. Six
experiments were performed each with tissue from
a different donor. Tissue was either pre-incubated
with sterile PBS or with 100 mg/ml M. avium FAP
(amino acids 269–292) and 100 mg/ml purified
M. bovis BCG a85B together by gently pipetting
onto the mucosal surface. Tissue was incubated at
371C for 15min and then washed ( 3) by gently
pipetting 100 ml of PBS onto the mucosal surface. A
clinical strain of MAC1 and MTB H37RV (ATCC 27294)
were used. Washed bacteria resuspended in 100 ml
of sterile PBS of which 2 ml containing approxi-
mately 1 108 cfu were inoculated onto each organ
culture. Viable counts were performed and there
was no significant difference between the inocula
of the different experiments. Tissues were incu-
bated at 371C in 5% CO2 in air for 15min, 7 days and
14 days. Organ cultures were then washed by
pipetting 100 ml (X3) of sterile PBS onto the tissue in
order to remove unattached bacteria. Then each of
the four edges of the organ culture were touched
with a sterile loop and plated onto Columbia agar
base (Lab M, Bury, UK) containing 5% defibrinated
horse blood and L.owenstein–Jensen (L–J) medium
(Royal Brompton Hospital, Microbiology Depart-
ment, London, UK), in order to assess the sterility
of the control organ cultures and the purity of the
mycobacterial growth in the infected organ cul-
tures. Tissue was removed from the organ culture
taking care to remove all surrounding agar. One
hundred microlitre of sterile PBS was placed in a
sterile-graduated centrifuge tube and the meniscus
was marked on the side of the tube. Tissue was
placed in the PBS and the displacement volume was
estimated by the amount of PBS required to be
removed to return the meniscus to the marked
level. The tissue was then placed in 1ml of sterile
PBS in a homogenizer grinder tube and homoge-
nized three times for 10 s, with a 10 s interval
between each spin to prevent temperature build-
up in the tissue/PBS due to friction. Ten-fold
dilutions of the homogenate were performed down
to 106. Viable counts were performed and the
number of bacteria recovered per microlitre of
tissue was calculated using the displacement
volume of the tissue. The number of MAC and
MTB recovered from tissue pre-incubated with PBS
was compared to the number recovered from tissue
pre-incubated with FAP and a85B at the three
incubation times. The number of bacteria recov-
ered at different time intervals were analysed using
Wilcoxon’s matched signed rank test, P-values of
p0:05 were judged to be significant. All experi-
ments were coded and randomized prior to analysis
making the observer blind to the identity of each
individual piece of tissue.
Results
The results at 15min reflect surface adherence,
whereas 7 and 14 days reflect a mixture of surface
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infection and tissue invasion. The figure shows the
mean number of bacteria recovered from macer-
ated organ culture tissue (cfu/ml) incubated for
15min, 7 and 14 days after pre-incubation of tissue
with either PBS or FAP and a85B together. The
numbers of MAC recovered from tissue pre-incu-
bated with FAP and a85B were reduced by 89.1%
(P ¼ 0:02), 88.8% (P ¼ 0:04) and 86.7% (P ¼ 0:03)
after 15min, 7 and 14 days incubation, respec-
tively, compared to tissue pre-incubated with PBS.
Therefore, inhibition of MAC adherence to fibro-
nectin substantially reduced the level of MAC
infection of the organ culture. The numbers of
MTB recovered from tissue pre-incubated with FAP
and a85B were reduced by 92.7% (P ¼ 0:01), but at
later time points there was no significant differ-
ence between organ cultures incubated with either
PBS or FAP and a85B together. There was a 35.5%
(P40:05) and 30.7% (P40:05) reduction in the FAP/
a85B incubated tissue at 7 and 14 days incubation,
respectively (Fig. 1).
Discussion
The significant reduction in MAC and MTB adhering
to tissue pre-incubated with FAP and a85B after
only 15min incubation was the same as shown in
our previous studies.1,2 In these studies, SEM
showed significant inhibition of mycobacterial
adherence to ECM, the major site of adherence.
The results of the extended incubation times, 7 and
14 days, showed that the numbers of MAC recov-
ered were still significantly reduced and the large
rise in MAC numbers recovered at 14 days, as seen
in the untreated control experiment, did not occur.
It may be that a critical number of MAC are
required before rapid multiplication can occur,
similar to the principle of ‘quorum sensing’
reported for other bacteria.12,13 These results show
that MAC infection of the organ culture is depen-
dent upon initial adherence to fibronectin. Our
previous studies show that bacteria replicate at
these sites to form discrete colonies. Therefore,
adherence to fibronectin is an important patho-
genic mechanism for MAC and could possibly
provide an opportunity to interrupt the infectious
process of binding could be inhibited in vivo.
However, the number of MTB recovered at 7 and
14 days were no different compared to untreated
control tissue. Therefore, in contrast to MAC,
inhibition of adherence to fibronectin does not
reduce MTB infection of the organ culture. This is
likely to be because MTB infection proceeds via
invasion of the mucosa, using mechanisms inde-
pendent of FAP and a85B, such as the heparin-
binding haemagglutinin described by Menozzi et al.
This study highlights differences in pathogenic
mechanisms of MAC and MTB with the respiratory
mucosa, despite similarities in their initial interac-
tion. Inhibition of MAC adherence to fibronectin,
for example by immunization with fibronectin
attachment proteins, could reduce mucosal infec-
tion by MAC.
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Figure 1 The mean number of M. avium complex (MAC)
and M. tuberculosis (TB) recovered from macerated
tissue (cfu/ml). Left shaded columns, 15min incubation;
clear, 7 days; right shaded, 14 days. MAC&PBS and
TB&PBS, pre-incubation of tissue with PBS;
MAC&FAP&85B and TB&FAP&85B, pre-incubation of tissue
with 100 mg/ml FAP and 100 mg/ml a85B together.
*P ¼ 0:02; ’ P ¼ 0:04; K P ¼ 0:03 MAC&PBS versus
MAC&FAP&85B at 15min, 7 and 14 days, respectively; m
P ¼ 0:01 TB&PBS versus TB&FAP&85B at 15min. Results
are expressed as the mean and standard error. n ¼ 6
(Turbinate ¼ 2, Bronchial ¼ 4).
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